Analytical solution development for the structural characterization of three nano-amorphous formulations of poorly soluble drugs with advantageous clinical pharmacokineti

The objective of the proposed work is to characterise three new drug formulations with improved solubility and dissolution characteristics. Special focus will be given to their particle related properties, like size, size distribution and their shapes.

Lead institution

NanGenex Nanotechnológiai Zártkörűen Működő Részvénytársaság (Druggability Technologies)